TB diagnosis: latest news

TB diagnosis resources

  • Tuberculosis

    Tuberculosis (TB) is an infection caused by bacteria that usually affects the lungs. With careful treatment it can be cured.TB is the single biggest cause...

    From: Factsheets

    Information level Level 2
  • Diagnosing TB

    Because the symptoms of TB can resemble those of other illnesses seen in people with HIV, doctors will often carry out a number of tests...

    From: Booklets

    Information level Level 2

TB diagnosis features

TB diagnosis in your own words

TB diagnosis news from aidsmap

More news

TB diagnosis news selected from other sources

  • UNITAID: Tuberculosis diagnostics technology and market landscape – 3rd edition

    UNITAID releases today its 2014 Tuberculosis Diagnostics Technology and Market Landscape, detailing the promising pipeline of products and technologies to diagnose tuberculosis (TB). The report highlights current and emerging technologies from over 80 manufacturers and developers, including products which are smaller, simpler and easier to use.

    01 October 2014 | EATG
  • From Rhetoric to Reality: An Analysis of Efforts to Scale Up The Response to TB-HIV

    A new research report from ACTION global health shows that joint TB-HIV activities are neglected by HIV programs and overwhelmingly carried out by TB programs, and that global guidelines to address TB-HIV have not been prioritized by leading donors and affected countries.

    22 July 2014 | ACTION
  • South Africa: Antiretrovirals Credited for TB Decline

    South Africa is seeing about 79,000 fewer TB cases annually thanks to increased HIV treatment uptake, according to the latest research from the National Institute for Communicable Diseases (NCID)

    13 June 2014 | Health-e
  • Mass TB Tests 'Would Save Billions'

    A World Bank study has estimated that South Africa, Lesotho, Swaziland, and Mozambique could save approximately 13 billion rand a year in increased productivity and reduced TB transmission by spending 330 million rand per year to test and treat miners in the gold and platinum mining industry for TB.

    31 March 2014 | Business Daily
  • Poor Diagnosis Driving Global Multidrug-Resistant TB, WHO Warns

    In 2012, fewer than 25 percent of the 500,000 people with multidrug-resistant TB (MDR TB) infections received a diagnosis, according to the World Health Organization (WHO). As a result, many MDR TB-infected individuals received the wrong treatment or no treatment at all.

    24 March 2014 | Reuters
  • South Africa Battles Drug-Resistant TB

    Despite an increase in diagnosis times, South Africa is facing a growing drug-resistant tuberculosis (TB) burden as nationally there remains a large gap between the number of patients diagnosed with multidrug-resistant TB (MDR-TB) and those who start treatment.

    12 March 2014 | Inter Press Service
  • Xpert TB test doesn’t reduce morbidity but it does have important advantages

    While it is disappointing that the Xpert did not confer a morbidity or mortality benefit, its advantages include quicker and easier diagnosis with less work for health workers.

    10 March 2014 | HIV i-Base
  • CROI 2014: GeneXpert real world study yields mixed results, highlights SA health system challenges

    Gavin Churchyard and Katherine Fielding presented results this morning from the XPert for TB: Evaluating a New Diagnostic Trial (EXTEND) on the question of whether Xpert MTB/RIF diagnostic test reduces early mortality in adults with suspected TB, facilitates earlier initiation of TB treatment and antiretroviral therapy and reduces the number of patients

    05 March 2014 | Science Speaks
  • GeneXpert use still hobbled by high pricing, Treatment Action Group, TB Community Advisory Board say

    Letter to Cepheid cites continued cost of machines, Russia, China cartridge costs of five to six times negotiated price, and more.

    28 January 2014 | Science Speaks
  • GLOBAL: Xpert MTB/RIF Test Quickly Detects TB and Resistance to Rifampicin

    News-Medical.net reported on a second systematic review of the Xpert® MTB/RIF TB test, which is endorsed by the World Health Organization (WHO). WHO commissioned this updated Cochrane Review as part of the process to update the policy on the use of the test.

    23 January 2014 | CDC National Prevention Information Network
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.